Nisarg Radadia1, Yonni Friedlander2,3, Norman B Konyer2, Mobin Jamal1, Chynna Huang3, Troy Farncombe 4,5, Christopher Marriott 4,5, Christian Finley3,6,7, John Agzarian3,6,7, Myrna Dolovich1,2,3, Michael D Noseworthy 2,4,8, Parameswaran Nair1,3, Yaron Shargall3,6,7, and Sarah Svenningsen1,2,3
1Department of Medicine, Division of Respirology, McMaster University, Hamilton, ON, Canada, 2Imaging Research Centre, St. Joseph's Healthcare Hamilton, Hamilton, ON, Canada, 3Firestone Institute for Respiratory Health, St. Joseph's Healthcare Hamilton, Hamilton, ON, Canada, 4Department of Radiology, McMaster University, Hamilton, ON, Canada, 5Department of Nuclear Medicine, St. Joseph's Healthcare Hamilton, Hamilton, ON, Canada, 6Division of Thoracic Surgery, Department of Surgery, McMaster University, Hamilton, ON, Canada, 7Division of Thoracic Surgery, St. Joseph's Healthcare Hamilton, Hamilton, ON, Canada, 8Department of Electrical and Computer Engineering, McMaster University, Hamilton, ON, Canada
Synopsis
Keywords: Lung, Hyperpolarized MR (Gas)
Previous studies have demonstrated the comparability of ventilation assessed by SPECT and hyperpolarized gas MRI methods; however, these comparisons were qualitative and limited to visual scoring methods based on radiologist reporting. Thus, we quantified the relationship between ventilation-defect-percent (VDP) assessed from same-day Technegas ventilation-SPECT and hyperpolarized
129Xe MRI, in patients with early-stage lung cancer. We observed that ventilation defects quantified by Technegas V-SPECT and
129Xe MRI VDP were correlated and increased in patients with COPD. A bias towards higher Technegas
V-SPECT VDP was detected and may be explained by differences in contrast agent
properties, image
acquisition conditions, and/or quantification pipelines.
Introduction
Pulmonary
ventilation imaging modalities have been developed to provide a regional
evaluation of airflow obstruction at high-resolution and may aid in the
clinical management of a variety of lung diseases. Nuclear medicine, magnetic resonance imaging
(MRI), and computed tomography (CT) based methods have all demonstrated abnormal
ventilation in patients with obstructive lung diseases, including chronic
obstructive pulmonary disease (COPD) and asthma, but few are widely available or used in
clinical practice.
Ventilation (V) single
photon emission computed tomography (SPECT) is a widely available and clinically
approved method that is primarily used in conjunction with perfusion (Q) SPECT for
the diagnosis of pulmonary embolism,1 but is rarely utilized to quantify ventilation
for other clinical indications. Alternatively, inhaled hyperpolarized xenon-129
(129Xe) gas MRI has undergone extensive research and development for
airway disease applications, but its availability is currently limited to
specialized academic centres. Previous studies have demonstrated comparability
of ventilation assessed by SPECT and hyperpolarized gas MRI methods,2–5 however these comparisons were
qualitative and limited to visual scoring methods based on radiologist
reporting.2,3 Thus, the objective of this study was
to quantify the relationship between ventilation defect percent (VDP), assessed
from same-day Technegas V-SPECT and hyperpolarized 129Xe MRI, in
patients with early-stage lung cancer. Methods
In a study approved
by our research ethics board, patients scheduled to undergo lung cancer
resection performed same-day Technegas V-SPECT-CT and hyperpolarized 129Xe
MRI one-week prior to surgery.
Ventilation SPECT using 99mTc Technegas: Technegas was prepared with a Technegas
Generator (Cyclomedica, Sydney) and a 40 MBq dose was administered to the patient
in a supine position via inhalation.
Following inhalation, V-SPECT was performed supine during tidal-breathing
using an Optima NM/CT 640 hybrid imaging system (GE Healthcare, Milwaukee) and
the following parameters: LEHR collimator, energy window: 140keV±10%, zoom
factor 1.0, 128x128 matrix, step and shoot, 25 seconds/image, 60 images/acquisition
(30 images/camera head), 360º rotation, 6º steps, body contour. Reconstruction
was performed using a Hermes workstation with the following settings: OSEM
reconstruction (2 iterations, 10 subsets), 3D Gaussian filter with 1.20cm FWHM
with corrections for attenuation, scatter, and collimator resolution recovery6.
Ventilation MRI using hyperpolarized 129Xe: Isotopically enriched 129Xe gas was polarized to 9-32% using
a commercially available polarizer system (Polarean 9800 or 9820, Polarean,
Durham). Following inhalation of a 1L
dose (600mL of 129Xe + 400mL of N2) from functional
residual capacity, 129Xe
static-ventilation images were acquired using a Discovery MR750 3.0T system (GE Healthcare;
Milwaukee), custom-built quadrature-asymmetric bird-cage
coil, and a 3D fast gradient recalled echo sequence (10s data acquisition, TE=1.5ms, TR=5.1ms, initial flip angle=1.3○, variable flip angle, receive bandwidth=16kHz,
FOV=40x40x24cm3; reconstructed matrix size=128x128x16; voxel size=3x3x15mm3)7.
Quantification
of the ventilation defect percent (VDP): The VDP was quantified for Technegas V-SPECT and 129Xe
MRI using previously described
adaptive threshold and
k-means pipelines, respectively8,9.
Statistics: Correlation and agreement between
VDP quantified by Technegas V-SPECT and 129Xe MRI were determined by
Spearman correlation and Bland-Altman analysis, respectively. Differences in
VDP based on history of lung disease (no history, asthma, COPD) was determined
using Kruskal Wallis with Tukey’s multiple comparisons test. Analyses were
performed using GraphPad Prism V9.2.1 (GraphPad Inc., San Diego).Results
Demographics and clinical characteristics for 41 participants (67±7
years old) that completed same day Technegas V-SPECT and 129Xe MRI are
summarized in Table 1. 22 (54%) reported no history of lung disease, while 10
(24%) and 6 (15%) reported a history of COPD and asthma, respectively. Technegas
V-SPECT and 129Xe MRI coronal slices for three representative participants
are shown in Figure 1. Participant 33 had homogenous ventilation visualized by
both modalities. Participants 16 and 59 had abnormal ventilation with spatially
concordant ventilation defects observed by both modalities. Figure 2 summarizes
the correlation and agreement of VDP measured by Technegas V-SPECT and 129Xe
MRI. VDP measured by both modalities were
correlated (r=0.65, p<0.0001).
Bland-Altman analysis indicated a statistically significant bias for
higher VDP measured by Technegas V-SPECT (23±14% vs 8±10%, p=0.0001). As shown
in Figure 3, VDP measured by both modalities was significantly higher for patients
with COPD than those with asthma and no history of lung disease.Discussion
In most participants, qualitative assessment showed spatial agreement
between ventilation defects observed by Technegas V-SPECT and 129Xe
MRI. The burden of ventilation defects quantified by Technegas V-SPECT and 129Xe
MRI VDP was correlated, with the burden increasing in participants with COPD.
Thus, both modalities exhibit sensitivity to airway obstruction. We did however
detect a statistically significant bias towards higher Technegas V-SPECT VDP. This
bias and lack of absolute agreement in VDP was not unexpected and may be
explained by several factors. Notably, V-SPECT and MRI have fundamental
differences in contrast agent properties (aerosolized particle vs. gas), inhalation technique (multi vs. single-breath), acquisition procedure
(15 minute tidal-breathing vs. 10 second breath-hold), and resolution. In addition, different registration and
segmentation pipelines were used to quantify VDP. Conclusion
The burden of ventilation
defects quantified by Technegas V-SPECT and 129Xe MRI VDP was
correlated and increased in patients with COPD.
A bias towards higher Technegas V-SPECT VDP was detected and may be
explained by differences in contrast agent properties and inhalation technique that
affect lung deposition, image acquisition conditions, and/or quantification
pipelines. Acknowledgements
This was an investigator initiated study funded by Cyclomedica Australia Pty Ltd. The funder had no role in the design of the study, the collection and analysis of data, or the preparation of the abstract.
We thank MRI technologists J. Lecomte, C. Awde, S. Weir, and S. Faseruk for performing the MRI and Nuclear Medicine technologists L. Speziale, M. Jamal for performing the SPECT/CT.
References
- Mirza, H. & Hashmi, M. F. Lung
Ventilation Perfusion Scan (VQ Scan). StatPearls (2021).
- Altes, T. A. et al. Ventilation
imaging of the lung: Comparison of hyperpolarized helium-3 MR imaging with
Xe-133 scintigraphy. Acad Radiol 11, 729–734 (2004).
- Stavngaard, T. et al.
Hyperpolarised 3He MRI and 81mKr SPECT in chronic obstructive pulmonary
disease. Eur J Nucl Med Mol Imaging 32, 448–457 (2005).
- Kim, M., Doganay, O., Matin, T., Povey,
T. & Gleeson, F. Comparison of the thoracic CT-based computational model
with hyperpolarized Xenon-129 MRI and SPECT images to assess pulmonary
ventilation in COPD patients. European Respiratory Journal 54,
OA1931 (2019).
- Doganay, O. et al. Time-series
hyperpolarized xenon-129 MRI of lobar lung ventilation of COPD in comparison
to V/Q-SPECT/CT and CT. Eur Radiol 29, 4058 (2019).
- Venegas, C. et al. Ventilation
and perfusion abnormalities following recovery from noncritical COVID-19. https://doi.org/10.1080/24745332.2022.2054047
(2022) doi:10.1080/24745332.2022.2054047.
- Svenningsen, S. et al.
Reproducibility of Hyperpolarized 129Xe MRI Ventilation Defect Percent in
Severe Asthma to Evaluate Clinical Trial Feasibility. Acad Radiol 28,
817–826 (2021).
- Farrow, C. E. et al. Peripheral
ventilation heterogeneity determines the extent of bronchoconstriction in
asthma. J Appl Physiol 123, 1188–1194 (2017).
- Kirby, M. et al. Hyperpolarized
3He Magnetic Resonance Functional Imaging Semiautomated Segmentation. Acad
Radiol 19, 141–152 (2012).